Literature DB >> 12626675

Differential effects of catecholamines on vascular rings from ductus venosus and intrahepatic veins of fetal sheep.

Mikhail Tchirikov1, Sonja Kertschanska, Hobe J Schröder.   

Abstract

Ductus venosus (DV) sparing means the maintenance of blood flow through the DV following reduction of liver venous blood supply during fetal hypoxia. The present study compared the reactions of the isthmic portion of the DV and intrahepatic veins (IHVs) to catecholamines in vitro. Vessel rings of 1 mm width and 3 mm diameter were obtained from 17 fetal sheep (88-136 days gestational age, median 120 days). The immunohistochemical examination of the DV and IHV was performed in eight cases using an antibody against alpha-smooth muscle actin and an antibody against alpha-adrenergic receptors. Five vessel rings of the DV in early gestation (median 95 days) did not respond to KCl-induced depolarisation. Force development in response to KCl of both vessel types increased with gestational age (P < 0.05). The IHV required 4.1 +/- 0.8 min (mean +/- S.E.M.) and the DV 14.5 +/- 4.0 min to reach the maximum tension in response to KCl, which was 5.0 +/- 4.0 mN in the IHV and 2.2 +/- 1.9 mN in the DV (n = 12, P < 0.05). The maximum forces developed in response to noradrenaline (norepinephrine; 42 microM, n = 9) and adrenaline (epinephrine; 100 microM, n = 12) were about sixfold higher in the IHV rings than in the DV rings (P < 0.05). The EC50 values of the DV and the IHV rings to noradrenaline were 5.9 +/- 1.3 microM and 5.0 +/- 1.3 microM, respectively (P = 0.03). The EC50 values of the adrenaline responses were 2.5 +/- 0.5 microM for the DV and 2.2 +/- 0.7 microM for the IHV (not significant). The alpha-adrenergic receptors were present in the well-structured media of IHVs, but were less distinctive in the wall of the DV. DV sparing can be attributed to an increased resistance of IHVs to catecholamines compared with the DV. The different responses can be explained by different anatomical and functional properties of the two vessel types.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12626675      PMCID: PMC2342862          DOI: 10.1113/jphysiol.2002.034470

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  19 in total

1.  Liver blood perfusion as a possible instrument for fetal growth regulation.

Authors:  M Tchirikov; S Kertschanska; H J Stürenberg; H J Schröder
Journal:  Placenta       Date:  2002-04       Impact factor: 3.481

2.  Doppler ultrasound measurements in the central circulation of anesthetized fetal sheep during obstruction of umbilical-placental blood flow.

Authors:  M Tchirikov; K Hecher; J Deprest; L Zikulnig; R Devlieger; H J Schröder
Journal:  Ultrasound Obstet Gynecol       Date:  2001-12       Impact factor: 7.299

3.  Ductus venosus blood velocity and the umbilical circulation in the seriously growth-retarded fetus.

Authors:  T Kiserud; S H Eik-Nes; H G Blaas; L R Hellevik; B Simensen
Journal:  Ultrasound Obstet Gynecol       Date:  1994-03-01       Impact factor: 7.299

4.  Umbilical flow distribution to the liver and the ductus venosus: an in vitro investigation of the fluid dynamic mechanisms in the fetal sheep.

Authors:  T Kiserud; L Stratford; M A Hanson
Journal:  Am J Obstet Gynecol       Date:  1997-07       Impact factor: 8.661

5.  Blood flow through the ductus venosus in singleton and multifetal pregnancies and in fetuses with intrauterine growth retardation.

Authors:  M Tchirikov; C Rybakowski; B Hüneke; H J Schröder
Journal:  Am J Obstet Gynecol       Date:  1998-05       Impact factor: 8.661

6.  Venous responses to hypoxemia in the fetal lamb.

Authors:  R P Paulick; R L Meyers; C D Rudolph; A M Rudolph
Journal:  J Dev Physiol       Date:  1990-08

7.  Assessment of fetal compromise by Doppler ultrasound investigation of the fetal circulation. Arterial, intracardiac, and venous blood flow velocity studies.

Authors:  K Hecher; S Campbell; P Doyle; K Harrington; K Nicolaides
Journal:  Circulation       Date:  1995-01-01       Impact factor: 29.690

8.  Redistribution of fetal circulation during repeated asphyxia in sheep: effects on skin blood flow, transcutaneous PO2, and plasma catecholamines.

Authors:  A Jensen; M Hohmann; W Künzel
Journal:  J Dev Physiol       Date:  1987-02

9.  Autonomic mechanisms in the ductus venosus of the lamb.

Authors:  F Coceani; A S Adeagbo; E Cutz; P M Olley
Journal:  Am J Physiol       Date:  1984-07

10.  Doppler ultrasound evaluation of ductus venosus blood flow during acute hypoxemia in fetal lambs.

Authors:  M Tchirikov; K Eisermann; C Rybakowski; H J Schröder
Journal:  Ultrasound Obstet Gynecol       Date:  1998-06       Impact factor: 7.299

View more
  5 in total

1.  The fetal dilemma: spare the brain and spoil the liver.

Authors:  Peter W Nathanielsz; Mark A Hanson
Journal:  J Physiol       Date:  2003-03-14       Impact factor: 5.182

2.  Endothelin-induced constriction of the ductus venosus in fetal sheep: developmental aspects and possible interaction with vasodilatory prostaglandin.

Authors:  A S O Adeagbo; L Kelsey; F Coceani
Journal:  Br J Pharmacol       Date:  2004-06-01       Impact factor: 8.739

3.  Altered development of fetal liver perfusion in pregnancies with pregestational diabetes.

Authors:  Agnethe Lund; Cathrine Ebbing; Svein Rasmussen; Torvid Kiserud; Mark Hanson; Jörg Kessler
Journal:  PLoS One       Date:  2019-03-13       Impact factor: 3.240

4.  Fetal liver blood flow distribution: role in human developmental strategy to prioritize fat deposition versus brain development.

Authors:  Keith M Godfrey; Guttorm Haugen; Torvid Kiserud; Hazel M Inskip; Cyrus Cooper; Nicholas C W Harvey; Sarah R Crozier; Sian M Robinson; Lucy Davies; Mark A Hanson
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

5.  The association of fetal and early childhood growth with adult mental distress: evidence from the johns hopkins collaborative perinatal study birth cohort.

Authors:  Aaron A Alford
Journal:  Front Psychiatry       Date:  2013-09-05       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.